Group News
Development Contract with the MOD
Sep 03, 2007Development Contract with the MOD’s Defence science and technology laboratory
Field Detection of Liquid Chemicals
Avacta Group plc (“Avacta”), which develops detection and analysis technology aimed at the defence & security, pharmaceutical and clinical diagnostics markets, announces a contract with the Defence science and technology laboratory (Dstl), which is part of the UK Ministry of Defence. Avacta is developing methods of analysing liquids using laser spectroscopy. The goal is to enable the rapid detection of liquids in the field.
Professor Alastair Smith, Chief Executive, Avacta, commented: “We are delighted with the new contract for the development of a robust, prototype device. Laser detection and diagnostic devices are a key part of Avacta’s portfolio of technologies and this contract with the MOD is an important step for the company.”
Enquiries:
| Avacta Group plcAlastair Smith, Chief Executive | Tel: 0870 835 4367 |
| Nexus Financial LtdNicholas Nelson/Kathy Boate | Tel: 020 7451 7050 |
| W.H. Ireland LtdDavid Youngman/Robin Gwyn | Tel: 0161 832 2174 |
| BankOra LtdMichael Brennan/Henry Turcan | Tel: 020 7099 1942 |
Notes to Editors: About AvactaAvacta was spun-out from the University of Leeds in 2004 by its current management team as a biophysics company, with the aim of combining the disciplines of physics and biology to develop innovative technologies and expert technical services to address needs in the pharmaceutical, defence and clinical diagnostics markets. Avacta has a core bio-analytical technology development programme addressing the needs of the biopharmaceutical sector to fully characterise their new products at the earliest stage in their development to reduce the risk of late stage failure. High value solutions in defence and clinical diagnostics are also being provided by Avacta’s development programmes. A successful and growing part of the Avacta business model is its technical services arm, Avacta Analytical Ltd which is focused on providing leading edge contract research to the biopharmaceutical and healthcare/personal-care materials sectors. Avacta listed on AIM in August 2006 through the reverse takeover of Readybuy plc which changed its name to Avacta Group plc.
Please click on the PDF icon to read the full article: